EUVIMEDEUVIMED entdecken
Open Access

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications

Yuyang Song, Laura A Bienvenu, Viktoria Bongcaron, Shania A Prijaya, Ana C Maluenda, Aidan P G Walsh, James D McFayden, Geoffrey A Pietersz, Karlheinz Peter, Xiaowei Wang

Theranostics · 2024

DOI: 10.7150/thno.97517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Yuyang Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Serum Albumin, Human, Thrombosis, Hemorrhage, Blood Platelets. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serum Albumin, HumanThrombosisHemorrhageBlood PlateletsAnimalsMiceHumansDisease Models, AnimalMaleAnticoagulantsSingle-Chain AntibodiesMyocardial Reperfusion InjuryMyocardial InfarctionMice, Inbred C57BLRecombinant Fusion Proteins

Stichwörter der Autor:innen

anticoagulantantiplatelettargeted drug deliverythromboprophylaxisthrombosis

Substanzen

Serum Albumin, HumanAnticoagulantsSingle-Chain AntibodiesRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Molecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Department of Cardiometabolic Health, University of Melbourne, VIC, Australia.
  • Baker Department of Cardiovascular Research, Translational and Implementation, La Trobe University, Melbourne, Australia.
  • Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Department of Medicine, Monash University, Melbourne, VIC, Australia.

Zitieren

APA

Song, Y., Bienvenu, L. A., Bongcaron, V., Prijaya, S. A., Maluenda, A. C., Walsh, A. P. G., McFayden, J. D., Pietersz, G. A., Peter, K., & Wang, X. (2024). Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications. Theranostics. https://doi.org/10.7150/thno.97517

Vancouver

Song Y, Bienvenu LA, Bongcaron V, Prijaya SA, Maluenda AC, Walsh APG, et al. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications. Theranostics. 2024. doi:10.7150/thno.97517

BibTeX
@article{Song2024,
  author = {Song, Yuyang and Bienvenu, Laura A and Bongcaron, Viktoria and Prijaya, Shania A and Maluenda, Ana C and Walsh, Aidan P G and McFayden, James D and Pietersz, Geoffrey A and Peter, Karlheinz and Wang, Xiaowei},
  title = {Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications},
  journal = {Theranostics},
  year = {2024},
  doi = {10.7150/thno.97517}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche